Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
77.40
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Moderna Announces Additional Supply for Q2 2022 of Vaccine for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
October 29, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at Upcoming Investor Conferences in November 2021
October 28, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Named a Top Employer by Science for Seventh Consecutive Year
October 28, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces First Participant Dosed in Phase 3 Pivotal Registration Study of Its mRNA Cytomegalovirus (CMV) Vaccine
October 26, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Swissmedic Authorizes Booster Dose of Moderna’s COVID-19 Vaccine
October 26, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Memorandum of Understanding to Supply up to 110 Million Doses of Its COVID-19 Vaccine to the African Union
October 26, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces European Medicines Agency’s Committee for Medicinal Products for Human Use Recommends Booster Dose of Moderna’s COVID-19 Vaccine in the European Union
October 25, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age
October 25, 2021
From
Moderna, Inc.
Via
Business Wire
U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine
October 21, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
October 20, 2021
From
Moderna, Inc.
Via
Business Wire
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
October 20, 2021
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
October 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Report Third Quarter Financial Results on Thursday, November 4, 2021
October 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s COVID-19 Vaccine for Low Income Countries in First Half of 2022
October 12, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year
October 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces the Launch of Global Fellowship Program for Young Researchers Exploring mRNA Medicines
October 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older
October 05, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Invest in New Science Center in Cambridge, MA
September 30, 2021
From
Moderna, Inc.
Via
Business Wire
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
September 28, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
September 28, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Supply Agreement with Peru for 20 Million Doses of Its COVID-19 Vaccine
September 24, 2021
From
Moderna, Inc.
Via
Business Wire
Rare Adverse Effects Continue to Fuel Covid-19 Vaccine Hesitancy, Despite Safety Breakthroughs
September 23, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
September 17, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
September 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna Announces Health Canada Approves its COVID-19 Vaccine
September 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Highlights New Clinical Data on its COVID-19 Vaccine
September 15, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day
September 09, 2021
From
Moderna, Inc.
Via
Business Wire
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
September 08, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1
September 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster
September 03, 2021
From
Moderna, Inc.
Via
Business Wire
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.